Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,067 hedge funds and large institutions have $51.7B invested in Allergan plc in 2018 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 363 increasing their positions, 419 reducing their positions, and 87 closing their positions.
33% more first-time investments, than exits
New positions opened: 116 | Existing positions closed: 87
17% more capital invested
Capital invested by funds: $44B → $51.7B (+$7.63B)
9% more funds holding in top 10
Funds holding in top 10: 45 → 49 (+4)
2% more funds holding
Funds holding: 1,044 → 1,067 (+23)
13% less repeat investments, than reductions
Existing positions increased: 363 | Existing positions reduced: 419
14% less call options, than puts
Call options by funds: $1.13B | Put options by funds: $1.32B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$519M |
| 2 |
Goldman Sachs
New York
|
+$212M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$155M |
| 4 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
+$135M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$127M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$345M |
| 2 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
-$257M |
| 3 |
SIG
Senator Investment Group
New York
|
-$184M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$153M |
| 5 |
Parnassus Investments
San Francisco,
California
|
-$147M |
AGN Hedge Fund Activity: Q3 2018 in Review
1,067 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2018, worth a combined $51.7B — up 17% from $44B a quarter earlier.
Buyers outnumbered sellers: 116 funds opened new AGN positions and 87 closed out — a net gain of 29 holders — while 363 added to existing stakes and 419 trimmed.
The largest buyer was Artisan Partners, adding an estimated $519M. The largest seller was Fidelity Investments, cutting an estimated $345M.
- 1,067 institutional investors held Allergan plc (AGN) as of Q3 2018, up from 1,044 in Q2 2018.
- Funds reported $51.7B of Allergan plc stock for Q3 2018, up 17% quarter-over-quarter.
- 116 funds opened new Allergan plc positions in Q3 2018 and 87 closed out, a net change of +29 holders.
- The largest Allergan plc buyer in Q3 2018 was Artisan Partners, an estimated $519M added.
- The largest Allergan plc seller in Q3 2018 was Fidelity Investments, an estimated $345M sold.
Based on aggregated 13F filings for Q3 2018.